Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy.
- DOI
- 10.1200/po.22.00197
- Published
- 2022 Sep
- Container
- JCO precision oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1200/po.22.00197,
title = {Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy.},
author = {Whitworth PW and Beitsch PD and Murray MK and Richards PD and Mislowsky A and Dul CL and Pellicane JV and Baron PL and Rahman RL and Lee LA and Dupree BB and Kelemen PR and Ashikari AY and Budway RJ and Lopez-Penalver C and Dooley W and Wang S and Dauer P and Menicucci AR and Yoder EB and Finn C and Blumencranz LE and Audeh W},
year = {2022},
journal = {JCO precision oncology},
doi = {10.1200/po.22.00197},
url = {https://doi.org/10.1200/po.22.00197}
}RIS
TY - JOUR TI - Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy. AU - Whitworth PW AU - Beitsch PD AU - Murray MK AU - Richards PD AU - Mislowsky A AU - Dul CL AU - Pellicane JV AU - Baron PL AU - Rahman RL AU - Lee LA AU - Dupree BB AU - Kelemen PR AU - Ashikari AY AU - Budway RJ AU - Lopez-Penalver C AU - Dooley W AU - Wang S AU - Dauer P AU - Menicucci AR AU - Yoder EB AU - Finn C AU - Blumencranz LE AU - Audeh W PY - 2022 JO - JCO precision oncology DO - 10.1200/po.22.00197 UR - https://doi.org/10.1200/po.22.00197 ER -
APA
PW, W., PD, B., MK, M., PD, R., A, M., CL, D., JV, P., PL, B., RL, R., LA, L., BB, D., PR, K., AY, A., RJ, B., C, L., W, D., S, W., P, D., AR, M., EB, Y., C, F., LE, B., & W, A. (2022). Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy.. JCO precision oncology. https://doi.org/10.1200/po.22.00197
Source records
- pubmed · retrieved 2026-09-25T08:34:40.597Z